Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Work In Process (2016 - 2025)

Standard Biotools (LAB) has disclosed Work In Process for 15 consecutive years, with $270000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Work In Process fell 82.67% to $270000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $270000.0, a 82.67% decrease, with the full-year FY2024 number at $443000.0, up 57.09% from a year prior.
  • Work In Process was $270000.0 for Q3 2025 at Standard Biotools, down from $414000.0 in the prior quarter.
  • In the past five years, Work In Process ranged from a high of $28.9 million in Q1 2025 to a low of $270000.0 in Q3 2025.
  • A 5-year average of $2.2 million and a median of $655000.0 in 2024 define the central range for Work In Process.
  • Biggest YoY gain for Work In Process was 4310.38% in 2025; the steepest drop was 82.67% in 2025.
  • Standard Biotools' Work In Process stood at $867000.0 in 2021, then rose by 9.0% to $945000.0 in 2022, then crashed by 70.16% to $282000.0 in 2023, then surged by 57.09% to $443000.0 in 2024, then crashed by 39.05% to $270000.0 in 2025.
  • Per Business Quant, the three most recent readings for LAB's Work In Process are $270000.0 (Q3 2025), $414000.0 (Q2 2025), and $28.9 million (Q1 2025).